Salako Omolola, Habeebu Muhammad Y, Okediji Paul T, Enyi Adaorah F, Okunade Kehinde S, Fagbenro Gabriel T, Maduafokwa Blossom A, Agha Oghenekome O, Abdulraheem Kamaldeen, Allsop Matthew J
Department of Radiation Biology, Radiotherapy & Radiodiagnosis, College of Medicine, University of Lagos, Lagos, Nigeria.
NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Support Care Cancer. 2025 Apr 5;33(4):356. doi: 10.1007/s00520-025-09293-0.
Cancer treatments such as chemotherapy immunotherapy and radiotherapy are associated with serious adverse effects that affect a patient's physiological functioning and physical appearance, contribute to financial toxicity, reduce quality of life, and increase the risk of treatment discontinuation. This systematic review aims to describe treatment-related side effects associated with non-surgical cancer treatment and clinical factors that influence the severity of side effects experienced among African cancer patients.
A systematic search of primary research studies reporting side effects of chemotherapy, radiotherapy, hormone therapy, targeted therapy, and immunotherapy among patients in African countries was undertaken across four databases (Medline (PubMed), ClinicalTrials.gov, Embase, and Cochrane Central Register of Controlled Trials).
Of the 7870 identified articles, 51 eligible studies were included . Articles outlined side effects from chemotherapy (n = 31), radiotherapy (n = 6), chemoradiation (n = 9), chemotherapy and targeted therapy (n = 2), and chemotherapy, radiotherapy, and targeted therapy (n = 3). The most prevalent side effects reported were nausea and vomiting (chemotherapy), radiation dermatitis (radiotherapy), neutropenia, and anaemia (chemoradiation). Included studies reported an increased risk of side effects related to combined therapy (i.e., chemoradiation), type of chemotherapy, higher cumulative chemotherapy doses, more frequent treatment cycles, and the presence of comorbidities. Six studies indicated treatment discontinuation arising due to treatment-related side effects.
The review highlights the need for cancer care providers to anticipate treatment-related side effects and mitigate them ahead of time, providing necessary prophylactic measures and treatment support.
化疗、免疫疗法和放射疗法等癌症治疗方法会带来严重的不良反应,这些反应会影响患者的生理功能和外貌,造成经济负担,降低生活质量,并增加治疗中断的风险。本系统评价旨在描述与非手术癌症治疗相关的治疗副作用,以及影响非洲癌症患者所经历副作用严重程度的临床因素。
对四个数据库(Medline(PubMed)、ClinicalTrials.gov、Embase和Cochrane对照试验中央注册库)进行系统检索,以查找报告非洲国家患者化疗、放疗、激素治疗、靶向治疗和免疫治疗副作用的原始研究。
在检索到的7870篇文章中,纳入了51项符合条件的研究。文章概述了化疗(n = 31)、放疗(n = 6)、放化疗(n = 9)、化疗和靶向治疗(n = 2)以及化疗、放疗和靶向治疗(n = 3)的副作用。报告的最常见副作用是恶心和呕吐(化疗)、放射性皮炎(放疗)、中性粒细胞减少和贫血(放化疗)。纳入的研究报告了联合治疗(即放化疗)、化疗类型、更高的累积化疗剂量、更频繁的治疗周期以及合并症的存在与副作用风险增加有关。六项研究表明因治疗相关副作用导致治疗中断。
该评价强调癌症护理提供者需要提前预测与治疗相关的副作用并加以缓解,提供必要的预防措施和治疗支持。